fashion -WSS

fashion

author：comprehensive 2025-10-01 21:48:42 - browse：834

Sarepta - Cambridge -AP — A logo sign outside of the headquarters of Sarepta Therapeutics in Cambridge, Mass. Kristoffer Tripplaar/Sipa via AP

Reviewers at the Food and Drug Administration were leaning toward rejecting a closely watched gene therapy for Duchenne muscular dystrophy made by Sarepta Therapeutics, prompting a top official to intervene earlier this year, according to three people with direct knowledge of the agency deliberations.

Inside the FDA office that oversees gene therapies, some staff had reached a non-binding conclusion that Sarepta’s gene therapy should be rejected, the individuals said, speaking on condition of anonymity. Peter Marks, a top FDA official and vocal advocate for faster gene therapy approvals, stepped in and directed staff to schedule a public hearing on the therapy on May 12.

Sarepta announced the scheduling of the public hearing last month, but the internal deliberations that led to it have not been previously reported.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Johnson & Johnson sues to stop Medicare negotiation

focus

knowledge

WSS

Twill hunts for pharma partner to market its depression app

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

Synthetic human embryos? Researchers say term is overblown

Manchin plays down potential 3rd

The simple reason for the increase in autism diagnosis

More hospitals are billing patients as online messages surge

Wikipedia

fashion

Wikipedia

Dobbs anniversary: the lost opportunity of abortion as health care

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

Affirmative action in medical school literally saved lives

Lack of darker skin in textbooks, journals harms patients of color

The cancer drug shortage isn’t new — and neither are the solutions

Robert Kennedy Jr.'s presidential campaign attracts GOP

Medical leaders decry Supreme Court decision on affirmative action

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

BioMarin wins approval for gene therapy to treat hemophilia A

The simple reason for the increase in autism diagnosis

hotspot

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

BridgeBio heart drug succeeds in pivotal study

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

Illumina to lay off 10% of research and development team

focus

knowledge

explore

hotspot